Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Bullboard Posts
Comment by dudediligenton Feb 23, 2012 12:15am
209 Views
Post# 19571127

RE: Market cap 3.89 million

RE: Market cap 3.89 million

Buying shares at one third the price from the recent highs makes sense to me. Market cap extremely low. How many devices would have to be sold yearly worldwide to increase your market cap ten fold.

 

 

MoleMate costs $4999, and comes with the proprietary software and scope, and 2 hr. training CD.

MoleMate also comes in a more advanced version, SIMSYS, which incorporates a robust data management system and imaging advances that allow physicians to more easily make side-by-side comparisons with earlier images of the same mole.  SIMSYS costs $7999, and includes a scope, and training CD.  SIMSYS also includes the more advanced visualization tools, data management system, and Mole Mapping, which is scheduled for release in early 2012, for a total cost of $10,000 when purchased with SIMSYS.

Bullboard Posts